Now worth $3.1 billion, NewLimit plans to test its RNA therapy in alcohol-related liver-disease patients next year.
Source link
Coinbase Founder’s Longevity Startup Triples in Value
Date:
More like thisRelated
Prosecutors Focus on Four Businesses Tied to Dodgers Owner Mark Walter
Proceeds from loans made by Walter’s insurers passed through...
Karl-Anthony Towns and Jordyn Woods wed in Malibu ceremony
Karl-Anthony Towns and Jordyn Woods have officially tied the...
Moroccan security forces arrest nearly 300 migrants trying to reach Spain’s Ceuta
CASABLANCA, Morocco -- Hundreds of migrants trying to reach...
Trump scales back joint military drills with South Korea
President Trump orders Pentagon to scale back joint exercises...